RICHARD /CA/ MURRAY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD /CA/ MURRAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD /CA/ MURRAY. RICHARD /CA/ MURRAY is Sr. VP & CSO in PDL BIOPHARMA, INC. ($PDLI) and Sr. VP & CSO in PDL BIOPHARMA, INC. ($PDLI) and SVP & CSO in PDL BIOPHARMA, INC. ($PDLI) and CEO and President in Jounce Therapeutics, Inc. ($JNCE).
Latest Insider Trading Transactions of RICHARD /CA/ MURRAY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 12.67 | 15,000 | 190,050 | 15,000 | |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 11.89 | 150,000 | 1,783,500 | 150,000 | |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 7,500 | 0 | 222,871 | 215.4 K to 222.9 K (+3.48 %) |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 75,000 | 0 | 215,371 | 140.4 K to 215.4 K (+53.43 %) |
| Jan 25 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 33,518 | 16,089 | 665,169 | |
| Jan 25 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 12.06 | 33,518 | 404,227 | 140,371 | 173.9 K to 140.4 K (-19.28 %) |
| Jan 25 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 33,518 | 16,089 | 173,889 | 140.4 K to 173.9 K (+23.88 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,482 | 7,911 | 698,687 | |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 40,000 | 19,200 | 715,169 | |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 30,000 | 14,400 | 755,169 | |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 12.04 | 16,482 | 198,443 | 140,371 | 156.9 K to 140.4 K (-10.51 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,482 | 7,911 | 156,853 | 140.4 K to 156.9 K (+11.74 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 9.59 | 40,000 | 383,600 | 140,371 | 180.4 K to 140.4 K (-22.18 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 40,000 | 19,200 | 180,371 | 140.4 K to 180.4 K (+28.50 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 8.54 | 30,000 | 256,200 | 140,371 | 170.4 K to 140.4 K (-17.61 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 30,000 | 14,400 | 170,371 | 140.4 K to 170.4 K (+21.37 %) |
| Jan 11 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 7.00 | 11,816 | 82,712 | 140,371 | 152.2 K to 140.4 K (-7.76 %) |
| Jan 11 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 6.76 | 10,183 | 68,837 | 152,187 | 162.4 K to 152.2 K (-6.27 %) |
| Feb 04 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 6.55 | 150,010 | 982,566 | 150,010 | |
| Feb 04 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 75,010 | 0 | 162,370 | 87.4 K to 162.4 K (+85.86 %) |
| Jan 10 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 7.78 | 7,150 | 55,627 | 87,360 | 94.5 K to 87.4 K (-7.57 %) |
| Jan 10 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 7.78 | 7,150 | 55,627 | 87,360 | 94.5 K to 87.4 K (-7.57 %) |
| Dec 26 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 40,000 | 19,200 | 785,169 | |
| Dec 26 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 8.37 | 40,000 | 334,800 | 94,510 | 134.5 K to 94.5 K (-29.74 %) |
| Dec 26 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 40,000 | 19,200 | 134,510 | 94.5 K to 134.5 K (+42.32 %) |
| Feb 05 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 4.40 | 125,010 | 550,044 | 125,010 | |
| Feb 05 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 62,510 | 0 | 94,510 | 32 K to 94.5 K (+195.34 %) |
| Sep 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 32,000 | 15,360 | 825,169 | |
| Sep 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 32,000 | 15,360 | 32,000 | 0 to 32 K |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,334 | 7,840 | 857,169 | |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 25.10 | 16,334 | 409,983 | 0 | 16.3 K to 0 (-100.00 %) |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,334 | 7,840 | 16,334 | 0 to 16.3 K |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,334 | 7,840 | 873,503 | |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 22.06 | 4,234 | 93,402 | 0 | 4.2 K to 0 (-100.00 %) |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 21.21 | 12,100 | 256,641 | 4,234 | 16.3 K to 4.2 K (-74.08 %) |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,334 | 7,840 | 16,334 | 0 to 16.3 K |
| Feb 05 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 23.98 | 200,000 | 4,796,000 | 200,000 | |
| Jul 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Payment of Exercise | F | 17.40 | 1,448 | 25,195 | 37,572 | 39 K to 37.6 K (-3.71 %) |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 15.25 | 1,875 | 28,594 | 39,688 | |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 13,125 | 103,031 | 30,625 | |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 32.02 | 1,875 | 60,038 | 39,020 | 40.9 K to 39 K (-4.58 %) |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 15.25 | 1,875 | 28,594 | 40,895 | 39 K to 40.9 K (+4.81 %) |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 32.02 | 452 | 14,473 | 39,020 | 39.5 K to 39 K (-1.15 %) |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 452 | 3,548 | 39,472 | 39 K to 39.5 K (+1.16 %) |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 32.00 | 12,673 | 405,536 | 39,020 | 51.7 K to 39 K (-24.52 %) |
| Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 12,673 | 99,483 | 51,693 | 39 K to 51.7 K (+32.48 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 15.25 | 3,437 | 52,414 | 41,563 | |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 6,563 | 51,520 | 43,750 | |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.99 | 1,200 | 34,788 | 39,020 | 40.2 K to 39 K (-2.98 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.75 | 2,237 | 64,314 | 40,220 | 42.5 K to 40.2 K (-5.27 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.75 | 5,863 | 168,561 | 42,457 | 48.3 K to 42.5 K (-12.13 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.74 | 100 | 2,874 | 48,320 | 48.4 K to 48.3 K (-0.21 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.73 | 500 | 14,365 | 48,420 | 48.9 K to 48.4 K (-1.02 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.72 | 100 | 2,872 | 48,920 | 49 K to 48.9 K (-0.20 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 15.25 | 3,437 | 52,414 | 49,020 | 45.6 K to 49 K (+7.54 %) |
| Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 6,563 | 51,520 | 45,583 | 39 K to 45.6 K (+16.82 %) |
| Aug 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 21,687 | 170,243 | 50,313 | |
| Aug 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 26.09 | 900 | 23,481 | 39,020 | 39.9 K to 39 K (-2.25 %) |
| Aug 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 26.17 | 9,100 | 238,126 | 39,920 | 49 K to 39.9 K (-18.56 %) |
| Aug 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 26.17 | 21,687 | 567,499 | 49,020 | 70.7 K to 49 K (-30.67 %) |
| Aug 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 21,687 | 170,243 | 70,707 | 49 K to 70.7 K (+44.24 %) |
| Jul 15 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | SVP & CSO | Grant | A | 0.00 | 16,200 | 0 | 49,020 | 32.8 K to 49 K (+49.36 %) |
| Jun 22 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 10,500 | 82,425 | 72,000 | |
| Jun 22 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.00 | 10,500 | 210,000 | 32,820 | 43.3 K to 32.8 K (-24.24 %) |
| Jun 22 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.00 | 10,500 | 210,000 | 43,320 | 53.8 K to 43.3 K (-19.51 %) |
| Jun 22 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 10,500 | 82,425 | 53,820 | 43.3 K to 53.8 K (+24.24 %) |
| Feb 02 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 2,500 | 19,625 | 82,500 | |
| Feb 02 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.06 | 2,500 | 50,152 | 43,320 | 45.8 K to 43.3 K (-5.46 %) |
| Feb 02 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.06 | 2,500 | 50,152 | 45,820 | 48.3 K to 45.8 K (-5.17 %) |
| Feb 02 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 2,500 | 19,625 | 48,320 | 45.8 K to 48.3 K (+5.46 %) |
| Jan 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 2,500 | 19,625 | 85,000 | |
| Jan 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.52 | 2,500 | 51,290 | 45,820 | 48.3 K to 45.8 K (-5.17 %) |
| Jan 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.52 | 2,500 | 51,290 | 48,320 | 50.8 K to 48.3 K (-4.92 %) |
| Jan 05 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 2,500 | 19,625 | 50,820 | 48.3 K to 50.8 K (+5.17 %) |
| Dec 15 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 5,000 | 39,250 | 87,500 | |
| Dec 15 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.01 | 5,000 | 100,033 | 48,320 | 53.3 K to 48.3 K (-9.38 %) |
| Dec 15 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.01 | 5,000 | 100,033 | 58,320 | 63.3 K to 58.3 K (-7.90 %) |
| Dec 15 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 5,000 | 39,250 | 63,320 | 58.3 K to 63.3 K (+8.57 %) |
| Oct 05 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 2,500 | 19,625 | 92,500 | |
| Oct 05 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.19 | 2,500 | 50,465 | 53,320 | 55.8 K to 53.3 K (-4.48 %) |
| Oct 05 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.19 | 2,500 | 50,465 | 55,820 | 58.3 K to 55.8 K (-4.29 %) |
| Oct 05 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 2,500 | 19,625 | 58,320 | 55.8 K to 58.3 K (+4.48 %) |
| Sep 14 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 10,000 | 78,500 | 95,000 | |
| Sep 14 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.00 | 10,000 | 200,000 | 55,820 | 65.8 K to 55.8 K (-15.19 %) |
| Sep 14 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 20.00 | 10,000 | 200,000 | 65,820 | 75.8 K to 65.8 K (-13.19 %) |
| Sep 14 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 10,000 | 78,500 | 75,820 | 65.8 K to 75.8 K (+15.19 %) |
| Jul 26 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | A | 15.30 | 45,000 | 688,500 | 45,000 | |
| Jul 26 2004 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | A | 15.30 | 60,000 | 918,000 | 60,000 |
Page: 1